The Academy of Managed Care Pharmacy (AMCP) is pleased to announce a strategic partnership with IPD Analytics. Through the partnership, select AMCP staff will have access to IPD Analytics’ platform and insights, which AMCP will use to inform resources we develop for our members. This collaboration will enhance AMCP’s and its members’ understanding of market dynamics, formulary trends, pharmacy cost considerations, and key market catalysts, supporting a shared goal of informed decision-making across health care stakeholders.

AMCP and AMCP Foundation are pleased to announce the recipients of the 2026 AMCP Awards, which honor individuals who have made significant contributions to the managed care profession and the AMCP organization. These awards are presented annually during the AMCP Annual Meeting.

In this video, Jessica of Chadds Ford, Pennsylvania, shares her journey living with eosinophilic esophagitis (EOE), a chronic inflammatory condition that causes difficulty swallowing and food impactions. After years of symptoms that were initially treated as acid reflux, a biopsy finally confirmed her diagnosis.

AMCP applauds the House reintroduction of the Medicaid VBPs for Patients (MVP) Act (H.R. 7871) by Rep. Brett Guthrie (KY-02) alongside Rep. Jake Auchincloss (MA-04), Rep. Mariannette Miller-Meeks (IA-01), Rep. John Joyce (PA-13), Rep. Scott Peters (CA-50), and Rep. Don Davis (NC-01). This bipartisan legislation complements Senate bill S. 1637 and aims to improve patient access to novel therapies by enhancing the use of value-based purchasing arrangements in Medicaid.

At the start of each year, AMCP brings together its Board, Foundation Officers, Committee & Affiliate leaders, and corporate partners for the Winter Leadership Meeting. It’s where we align on priorities, strengthen relationships, and ensure the work ahead reflects AMCP’s mission and trends and topics in managed care pharmacy.

As pharmacy benefit management grows more complex, managed care organizations are increasingly relying on advanced analytical tools and RWE to guide coverage decisions, streamline utilization management, and support value-based reimbursement strategies. With specialty therapies commanding rising spend and policy shifts affecting patient access and affordability, the integration of AI and RWE is gaining traction among payers and their partners as a strategic imperative.